62 filings
Page 3 of 4
8-K
vmu mrrg6eeqj
19 Nov 21
Entry into a Material Definitive Agreement
6:08am
8-K
0qea9 vpv9v
15 Nov 21
Mirum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
l5zbq8
29 Sep 21
U.S. FDA Approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome One Year of Age and Older
4:42pm
8-K
2grf l154kymu
20 Aug 21
Mirum Pharmaceuticals Appoints Biotechnology Executive William C. Fairey to its Board of Directors
12:00am
8-K
c9ot2cb4
5 Aug 21
Mirum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
4:36pm
8-K
lmnbvpmxkhajzz5l428
9 Jun 21
Mirum Pharmaceuticals Appoints Veteran Biotechnology Executive Carol L. Brosgart, M.D. to Board of Directors
4:17pm
8-K
cvllj2g1 d9
6 May 21
Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
niimer2m
29 Mar 21
Other Events
4:17pm
8-K
eupej7
9 Mar 21
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Results and Provides Business Updates
4:05pm
8-K
7emzvivse rkuen9yv44
12 Jan 21
Mirum Pharmaceuticals Provides Corporate Update
9:10am
8-K
43402n 0m1wkk
15 Dec 20
Other Events
5:09pm
8-K
teqs6
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
8-K
6uwqefv9 6y9c
12 Nov 20
Mirum Pharmaceuticals Provides Third Quarter 2020 Financial Results and Business Update, and Announces Virtual Investor Day
6:06am
8-K
s3lzemnpd4i zd3
6 Aug 20
Mirum Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Clinical Program Updates
4:05pm
8-K
3iam6yl12hc n24
16 Jun 20
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
f8nkfqeh9ynzcr6g0dd9
7 May 20
Mirum Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Updates
4:06pm
8-K
38f ri80v46qm2
12 Mar 20
Mirum Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
4:05pm
8-K
qy1pwu1l
14 Jan 20
Departure of Directors or Certain Officers
4:00pm
8-K
h2kia pl5y7rr
27 Dec 19
Departure of Directors or Certain Officers
4:15pm
8-K
1ucvpmpwn1g7 infca0
6 Nov 19
Mirum Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
4:05pm